List view / Grid view
29 April 2016 | By 3rd Pharmaceutical Traceability Forum
Harmonize serialization plans to achieve compliance. Supply chain stakeholders must take a comprehensive view of their traceability strategy...
28 April 2016 | By Victoria White, Digital Content Producer
Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi...
28 April 2016 | By Victoria White, Digital Content Producer
Adocia and Lilly have announced positive topline results from a Phase Ib trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro...
28 April 2016 | By Victoria White, Digital Content Producer
The double-blinded SUSTAIN6 trial investigated the long-term cardiovascular and other safety outcomes of 0.5 mg and 1.0 mg semaglutide compared with placebo...
27 April 2016 | By Mandy Parrett, Editorial Assistant
Novartis announced today that the FDA has granted three breakthrough therapy designations for Ilaris® (canakinumab) to treat rare types of Periodic Fever Syndromes, also known as Hereditary Periodic Fevers.
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow is the only company in the world able to provide a complete package of fluid path technology expertise to the biotechnology industries...
27 April 2016 | By Watson-Marlow Fluid Technology Group
Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow Fluid Technology Group has introduced its new 530 peristaltic cased pump for upstream and downstream bioprocessing tasks...
27 April 2016 | By Victoria White, Digital Content Producer
Researchers at are using so-called "machine learning" technologies to predict whether patients will participate in clinical trials...
27 April 2016 | By Victoria White, Digital Content Producer
The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure.
27 April 2016 | By Victoria White, Digital Content Producer
The decision from the EC was based on data from the international, double-blind, placebo-controlled Phase III RECOURSE study...
27 April 2016 | By Victoria White, Digital Content Producer
The guidance recommends paclitaxel and PLDH for treating ovarian cancer that has returned after previous chemotherapy treatment...
26 April 2016 | By Victoria White, Digital Content Producer
Norovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...
26 April 2016 | By Victoria White, Digital Content Producer
Alizé Pharma has announced top-line results of a Phase II clinical trial of AZP-531 in patients with Prader-Willi Syndrome (PWS)...
26 April 2016 | By Victoria White, Digital Content Producer
The EC has granted marketing authorisation for Lilly’s ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults...
